Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) — Stella

Home/Heart Failure With Preserved Ejection Fraction (HFpEF)/

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure With Preserved Ejection Fraction (HFpEF) trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Northwestern Medicine, Chicago, Illinois

UT Southwestern Medical Center, Dallas, Texas

Key details

Phase

Early testing

Sponsor

Secretome Therapeutics

Enrollment target

~12 participants

Started

March 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.